| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 35.52B | 35.10B | 34.70B | 38.09B | 36.12B | 34.16B |
| Gross Profit | 3.59B | 3.54B | 3.41B | 3.82B | 3.53B | 3.19B |
| EBITDA | 4.17B | 4.00B | 3.73B | 4.02B | 3.38B | 3.00B |
| Net Income | 1.22B | 1.13B | 980.00M | 1.27B | 1.13B | 802.00M |
Balance Sheet | ||||||
| Total Assets | 50.52B | 50.99B | 48.44B | 46.31B | 47.58B | 41.77B |
| Cash, Cash Equivalents and Short-Term Investments | 3.91B | 4.89B | 2.66B | 2.92B | 3.83B | 3.29B |
| Total Debt | 15.96B | 16.08B | 14.06B | 14.89B | 16.55B | 12.14B |
| Total Liabilities | 22.79B | 23.46B | 21.89B | 22.43B | 24.71B | 19.94B |
| Stockholders Equity | 27.54B | 27.35B | 26.40B | 23.73B | 22.73B | 21.71B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -821.00M | 951.00M | 17.00M | -3.05B | 757.00M |
| Operating Cash Flow | 0.00 | 2.15B | 2.60B | 4.18B | 2.79B | 2.48B |
| Investing Cash Flow | 0.00 | -2.22B | -1.10B | -4.18B | -5.94B | -1.79B |
| Financing Cash Flow | 0.00 | 2.29B | -1.76B | -945.00M | 3.68B | 383.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥12.99B | 8.60 | ― | 2.98% | 4.56% | 30.80% | |
77 Outperform | ¥15.01B | 11.37 | ― | 3.63% | 3.18% | -23.51% | |
73 Outperform | ¥12.42B | 8.94 | ― | 4.02% | 4.96% | 38.49% | |
71 Outperform | ¥9.42B | 6.01 | ― | 1.83% | -0.59% | 75.89% | |
70 Outperform | ¥17.62B | 7.80 | ― | 2.60% | 7.13% | 16.09% | |
68 Neutral | ¥4.92B | 8.89 | ― | 1.60% | 3.99% | 151.46% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |